Ask
Search
My library

About
Statistics
Contact
Data Protection
Accessibility
Imprint
Changelog
Frontend: v1.31.3
Backend: v1.11.4

We use cookies to provide a better user experience.

Data Protection

Time to target evaluation criteria of targeted therapies.

Herpen, C.M.L. van
Graaf, W.T.A. van der
Oyen, W.J.G.

Publication date

January 2009

DOI

10.1097/MNM.0b013e3283294d32

Publisher

Ovid Technologies (Wolters Kluwer Health)

ISSN

0143-3636

Abstract

Contains fulltext : 81113.pdf (publisher's version ) (Closed access

Extracted data

Related items

Patients' Evaluation of a Preparatory Online Communication Tool for Older Patients With Cancer Preceding Chemotherapy

Driesenaar, Jeanine A.
Dulmen, S. van
Weert, Julia C.M. van
Noordman, J.

January 2020

Contains fulltext : 217768.pdf (Publisher’s version ) (Closed access

Dendritic cell immunotherapy: mapping the way

Figdor, C.G.
Vries, I.J.M. de
Lesterhuis, W.J.
Melief, C.J.M.

January 2004

Contains fulltext : 27230.pdf (publisher's version ) (Closed access

Development of infection and inflammation targeting compounds.

Laverman, P.
Bleeker-Rovers, C.P.
Corstens, F.H.M.
Boerman, O.C.
Oyen, W.J.G.

January 2008

Contains fulltext : 69940.pdf (publisher's version ) (Closed access

Targeted therapies: summary clinical trials working group.

Weinblatt, M.E.
Riel, P.L.C.M. van

January 2006

Contains fulltext : 50385.pdf (publisher's version ) (Closed access

Targeted therapy in nuclear medicine: current status and future prospects.

Oyen, W.J.G.
Bodei, L.
Giammarile, F.
Maecke, H.R.
Tennvall, J.
Luster, M.
Brans, B.

January 2008

Contains fulltext : 70862.pdf (publisher's version ) (Closed access

Time to Akt: Superior tumor-reactive T cells for adoptive immunotherapy

Waart, A.B. van der
Hobo, W.
Dolstra, H.

January 2015

Contains fulltext : 154298.pdf (publisher's version ) (Closed access

Finding and explaining optimal treatments

Bielza, C.
Pozo, J.A.F. del
Lucas, P.

January 2003

Contains fulltext : 112472.pdf (publisher's version ) (Closed access

Advanced monitoring of targeted therapy in cancer.

Desar, I.M.E.

January 2010

Contains fulltext : mmubn000001_537452117.pdf (publisher's version ) (Closed acces...

Time to recognise countries' preferences in HIV control

Tromp, N.
Prawiranegara, R.
Siregar, A.Y.M.
Jansen, M.P.M.
Baltussen, R.M.

January 2016

Contains fulltext : 170051.pdf (publisher's version ) (Closed access

Optimizing the efficacy of exposure in PTSD treatment

Hendriks, G.J.
Kleine, R.A. de
Minnen, A. van

January 2015

Contains fulltext : 140446.pdf (publisher's version ) (Open Access)2 p

Assessment of individual treatment preferences for T3-laryngeal cancer; effects of time and disease and treatment related knowledge (abstract)

Donk, J. van der
Krabbe, P.F.M.
Habbema, J.D.F.
Levendag, P.C.
Meeuwis, C.A.
Schmitz, P.I.M.

January 1995

Contains fulltext : 21177___.PDF (publisher's version ) (Open Access

[The patient chooses for feasibility and effectiveness],[The patient chooses for feasibility and effectiveness]

Stalmeier, P.F.M.
Tol-Geerdink, J.J. van
Lin, E.N.J.T. van
Schimmel, E.
Huizenga, H.
Daal, W.A.J. van
Leer, J.W.H.

January 2009

Contains fulltext : 79743.pdf (publisher's version ) (Closed access

Biomarkers for therapeutic efficacy.

Brunner, N.
Nielsen, K.V.
Offenberg, H.
Sweep, C.G.J.
Martens, J.
Foekens, J.A.
Folprecht, G.
Lutz, M.P.
Mechetner, E.

January 2007

Contains fulltext : 187132.pdf (publisher's version ) (Open Access

Duration of antibiotic treatment: are even numbers odd?

Alp, E.
Hoeven, J.G. van der
Verweij, P.E.
Mouton †, J.W.
Voss, A.

January 2005

Contains fulltext : 48812.pdf (publisher's version ) (Closed access

Developing and selecting interventions for translating knowledge to action.

Wensing, M.J.P.
Bosch, M.
Grol, R.P.T.M.

January 2010

Contains fulltext : 88473.pdf (publisher's version ) (Closed access

Patients' Evaluation of a Preparatory Online Communication Tool for Older Patients With Cancer Preceding Chemotherapy

Driesenaar, Jeanine A.
Dulmen, S. van
Weert, Julia C.M. van
Noordman, J.

January 2020

Contains fulltext : 217768.pdf (Publisher’s version ) (Closed access

Dendritic cell immunotherapy: mapping the way

Figdor, C.G.
Vries, I.J.M. de
Lesterhuis, W.J.
Melief, C.J.M.

January 2004

Contains fulltext : 27230.pdf (publisher's version ) (Closed access

Development of infection and inflammation targeting compounds.

Laverman, P.
Bleeker-Rovers, C.P.
Corstens, F.H.M.
Boerman, O.C.
Oyen, W.J.G.

January 2008

Contains fulltext : 69940.pdf (publisher's version ) (Closed access

Targeted therapies: summary clinical trials working group.

Weinblatt, M.E.
Riel, P.L.C.M. van

January 2006

Contains fulltext : 50385.pdf (publisher's version ) (Closed access

Targeted therapy in nuclear medicine: current status and future prospects.

Oyen, W.J.G.
Bodei, L.
Giammarile, F.
Maecke, H.R.
Tennvall, J.
Luster, M.
Brans, B.

January 2008

Contains fulltext : 70862.pdf (publisher's version ) (Closed access

Time to Akt: Superior tumor-reactive T cells for adoptive immunotherapy

Waart, A.B. van der
Hobo, W.
Dolstra, H.

January 2015

Contains fulltext : 154298.pdf (publisher's version ) (Closed access

Finding and explaining optimal treatments

Bielza, C.
Pozo, J.A.F. del
Lucas, P.

January 2003

Contains fulltext : 112472.pdf (publisher's version ) (Closed access

Advanced monitoring of targeted therapy in cancer.

Desar, I.M.E.

January 2010

Contains fulltext : mmubn000001_537452117.pdf (publisher's version ) (Closed acces...

Time to recognise countries' preferences in HIV control

Tromp, N.
Prawiranegara, R.
Siregar, A.Y.M.
Jansen, M.P.M.
Baltussen, R.M.

January 2016

Contains fulltext : 170051.pdf (publisher's version ) (Closed access

Optimizing the efficacy of exposure in PTSD treatment

Hendriks, G.J.
Kleine, R.A. de
Minnen, A. van

January 2015

Contains fulltext : 140446.pdf (publisher's version ) (Open Access)2 p

Assessment of individual treatment preferences for T3-laryngeal cancer; effects of time and disease and treatment related knowledge (abstract)

Donk, J. van der
Krabbe, P.F.M.
Habbema, J.D.F.
Levendag, P.C.
Meeuwis, C.A.
Schmitz, P.I.M.

January 1995

Contains fulltext : 21177___.PDF (publisher's version ) (Open Access

[The patient chooses for feasibility and effectiveness],[The patient chooses for feasibility and effectiveness]

Stalmeier, P.F.M.
Tol-Geerdink, J.J. van
Lin, E.N.J.T. van
Schimmel, E.
Huizenga, H.
Daal, W.A.J. van
Leer, J.W.H.

January 2009

Contains fulltext : 79743.pdf (publisher's version ) (Closed access

Biomarkers for therapeutic efficacy.

Brunner, N.
Nielsen, K.V.
Offenberg, H.
Sweep, C.G.J.
Martens, J.
Foekens, J.A.
Folprecht, G.
Lutz, M.P.
Mechetner, E.

January 2007

Contains fulltext : 187132.pdf (publisher's version ) (Open Access

Duration of antibiotic treatment: are even numbers odd?

Alp, E.
Hoeven, J.G. van der
Verweij, P.E.
Mouton †, J.W.
Voss, A.

January 2005

Contains fulltext : 48812.pdf (publisher's version ) (Closed access

Developing and selecting interventions for translating knowledge to action.

Wensing, M.J.P.
Bosch, M.
Grol, R.P.T.M.

January 2010

Contains fulltext : 88473.pdf (publisher's version ) (Closed access

Patients' Evaluation of a Preparatory Online Communication Tool for Older Patients With Cancer Preceding Chemotherapy

Driesenaar, Jeanine A.
Dulmen, S. van
Weert, Julia C.M. van
Noordman, J.

January 2020

Contains fulltext : 217768.pdf (Publisher’s version ) (Closed access

Dendritic cell immunotherapy: mapping the way

Figdor, C.G.
Vries, I.J.M. de
Lesterhuis, W.J.
Melief, C.J.M.

January 2004

Contains fulltext : 27230.pdf (publisher's version ) (Closed access

Development of infection and inflammation targeting compounds.

Laverman, P.
Bleeker-Rovers, C.P.
Corstens, F.H.M.
Boerman, O.C.
Oyen, W.J.G.

January 2008

Contains fulltext : 69940.pdf (publisher's version ) (Closed access